Previsioni del mercato europeo degli integratori probiotici per neonati, bambini e materni fino al 2028 – Impatto del COVID-19 e analisi regionale – per forma (capsule e gel morbidi, caramelle gommose, liquidi e altri) e utente finale (neonati e bambini piccoli, bambini , e donne materne)
Si prevede che il mercato europeo degli integratori probiotici per neonati, bambini e mamme cresca da 179,18 milioni di dollari nel 2022 a 287,30 milioni di dollari entro il 2028; si stima che crescerà a un CAGR dell\'8,2% dal 2022 al 2028.
Le donne incinte cercano varie alternative per supportare la loro forma fisica e la salute dei loro bambini non ancora nati. Problemi digestivi, come stitichezza, diarrea, acidità e infiammazione, sono comuni durante la gravidanza. Recentemente, la domanda di integratori alimentari probiotici tra le donne incinte è aumentata. I ceppi probiotici accuratamente studiati aiutano a migliorare il movimento intestinale e ad alleviare i problemi di stitichezza. Il consumo di integratori probiotici nella dieta regolare aiuta a ridurre l’infiammazione, l’acidità e il gonfiore e riduce anche il rischio di infezioni vaginali, diminuendo così le possibilità di coliche, eczema e altre allergie nei neonati. Inoltre, riduce anche il rischio di preeclampsia nelle donne in gravidanza, una condizione di salute che provoca ipertensione e alti livelli di proteine nelle urine. Gli integratori probiotici garantiscono inoltre una migliore immunità alle donne incinte, che aiuta a combattere le malattie croniche e garantire la buona salute del bambino. Lactobacillus acidophilus, Bifidobacterium bifidum e Saccharomyces boulardii sono tra i ceppi probiotici più efficaci e ampiamente utilizzati negli integratori probiotici prenatali. Questi ceppi aiutano a mantenere una flora intestinale sana e riducono il rischio di varie allergie, malattie e complicanze, tra cui il diabete gestazionale e la preeclampsia. La crescente consapevolezza sui benefici degli integratori probiotici tra le donne incinte e i neonati sta sostanzialmente guidando la crescita del mercato degli integratori probiotici per neonati, bambini e materni.
Con nuove funzionalità e tecnologie, i fornitori possono attrarre nuovi clienti ed espandere la propria impronte nei mercati emergenti. È probabile che questo fattore guidi la crescita del mercato europeo degli integratori probiotici per neonati, bambini e materni a un CAGR notevole durante il periodo di previsione.
Europa infantile Entrate e previsioni del mercato degli integratori probiotici per neonati, bambini e materni fino al 2028 (milioni di dollari)
Mercato europeo degli integratori probiotici per neonati, bambini e materni Segmentazione
Il mercato europeo degli integratori probiotici per neonati, bambini e materni è segmentato in forma, utente finale e paese. In base alla forma, il mercato è classificato in capsule e gel morbidi, caramelle gommose, liquidi e altri. In base all\'utente finale, il mercato è segmentato in neonati e bambini piccoli, bambini e donne materne. In base al Paese, il mercato europeo degli integratori probiotici per neonati, bambini e mamme è segmentato in Germania, Regno Unito, Francia, Italia, Russia e resto d\'Europa.
Mercato europeo degli integratori probiotici per neonati, bambini e materni: Aziende citate
Bayer Corporation, Nestlé SA, BioGaia AB e Nordic Naturals sono alcune delle principali aziende che operano nel mercato europeo degli integratori probiotici per neonati, bambini e materni.
Europe Infant, Child, and Maternal Probiotic Supplements Strategic Insights
Strategic insights for Europe Infant, Child, and Maternal Probiotic Supplements involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Get more information on this report
Europe Infant, Child, and Maternal Probiotic Supplements Report Scope
Report Attribute
Details
Market size in 2022
US$ 179.18 Million
Market Size by 2028
US$ 287.30 Million
Global CAGR (2022 - 2028)
8.2%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Forma
Capsule e Softgel
Gommose
Liquido
By Utente finale
neonati e bambini piccoli
bambini
donne in gravidanza
Regions and Countries Covered
Europa
Regno Unito
Germania
Francia
Russia
Italia
resto Europa
Market leaders and key company profiles
Bayer Corporation
Nestlé S.A.
BioGaia AB
Nordic Naturals
Get more information on this report
Europe Infant, Child, and Maternal Probiotic Supplements Regional Insights
The regional scope of Europe Infant, Child, and Maternal Probiotic Supplements refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Europe Infant, Child, and Maternal Probiotic Supplements Market
Bayer Corporation
Nestlé S.A.
BioGaia AB
Nordic Naturals
Frequently Asked Questions
How big is the Europe Infant, Child, and Maternal Probiotic Supplements Market?
The Europe Infant, Child, and Maternal Probiotic Supplements Market is valued at US$ 179.18 Million in 2022, it is projected to reach US$ 287.30 Million by 2028.
What is the CAGR for Europe Infant, Child, and Maternal Probiotic Supplements Market by (2022 - 2028)?
As per our report Europe Infant, Child, and Maternal Probiotic Supplements Market, the market size is valued at US$ 179.18 Million in 2022, projecting it to reach US$ 287.30 Million by 2028. This translates to a CAGR of approximately 8.2% during the forecast period.
What segments are covered in this report?
The Europe Infant, Child, and Maternal Probiotic Supplements Market report typically cover these key segments-
Forma (Capsule e Softgel, Gommose, Liquido)
Utente finale (neonati e bambini piccoli, bambini, donne in gravidanza)
What is the historic period, base year, and forecast period taken for Europe Infant, Child, and Maternal Probiotic Supplements Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Infant, Child, and Maternal Probiotic Supplements Market report:
Historic Period : 2020-2021
Base Year : 2022
Forecast Period : 2023-2028
Who are the major players in Europe Infant, Child, and Maternal Probiotic Supplements Market?
The Europe Infant, Child, and Maternal Probiotic Supplements Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Bayer Corporation
Nestlé S.A.
BioGaia AB
Nordic Naturals
Who should buy this report?
The Europe Infant, Child, and Maternal Probiotic Supplements Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Europe Infant, Child, and Maternal Probiotic Supplements Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Europe Infant, Child, and Maternal Probiotic Supplements Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines